PMP Blog

The PMP Blog offers updates and resources for providers who use the PMP. The posts include timely information and guidance for effective use of the PMP to improve communication and patient-centered care.

Nov 2021

Protect Your Patients with the Texas PMP & Naloxone

Unintentional overdose involving prescription opioids is a leading cause of injury-related deaths in the United States. Checking the Texas Prescription Monitoring Program (PMP) for every patient, every time is an evidence-based strategy to help prevent drug interactions, prescription opioid misuse, and overdose deaths. Along with checking the PMP, the U.S. Food & Drug Administration (FDA) recommends prescribers discuss the availability of naloxone — a life-saving medication that rapidly reverses the effects of an opioid overdose — with all patients prescribed opioids. Additionally, both the FDA and the Centers for Disease Control (CDC) recommend considering co-prescribing it to patients who are at increased risk of opioid overdose.

How Naloxone works

Naloxone is an opioid antagonist that blocks the effects of opioids. If a person is experiencing respiratory depression from an overdose, naloxone helps them breathe normally again. Naloxone is not a controlled substance and cannot be misused. Naloxone only works when there are opioids in a person’s system — the medication has no effect if opioids are absent.

Talking to patients about Naloxone

When you discuss or co-prescribe naloxone, you make it clear that opioid medications have risks — and you want your patient to be aware of those risks. Should a bad reaction to opioids or accidental ingestion by another family member occur, having the tool to reverse it on-hand acts as a safety net.

After reviewing your patient’s prescription history in the PMP, try beginning the conversation like this: “Now that we’ve discussed the purpose and risks of your medication, I want to tell you about naloxone. It’s recommended that every time someone receives a prescription opioid, we discuss the possibility of a prescription for naloxone. Having it just in case of a bad reaction can keep you safe when taking prescription opioids.”

If your patient is hesitant to discuss naloxone, you can increase buy-in by explaining the benefits and emphasizing that you’re not going to change their existing medication regimen.

Learn more about Naloxone and the Texas PMP

Co-prescribing naloxone is an effective risk-reduction strategy to provide additional safety for your patients at increased risk of overdose. For more information about naloxone and other risk-reduction strategies, visit for free CME programs and clinical materials.

Back to Blog